Dr. Changming An 安常明
Chief Physician, Associate Professor
Department of Head and Neck Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Refined thyroid cancer surgery. Surgical treatment and functional reconstruction for laryngeal, hypopharyngeal, cervical esophageal, oral, nasal sinus, and salivary gland tumors.
Dr. An is Deputy Director of Head and Neck Surgery and a master’s supervisor. After graduating from Sun Yat-sen University in 2002, Dr. An worked at Guangdong Provincial People’s Hospital. From 2004 to 2010, Dr. An earned master’s and doctoral degrees at Peking Union Medical College and has remained on staff since. Research focuses on functional surgery and basic studies for thyroid and head and neck squamous cell carcinomas.
Professional roles
- Member, Chinese Medical Association
Name order: in Chinese the family name comes first (An Changming). Papers usually list the name as Changming An or An C.
Selected publications
67 papers on PubMed matched by name and affiliation; 16 as first or senior author since 2016. Most recent first- or senior-author papers:
- World J Otorhinolaryngol Head Neck Surg, 2026 (senior author): Biomarkers Predictive of Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma: Current Insights and Future Perspectives. PubMed 42500053
- Front Oncol, 2026 (senior author): Neoadjuvant ctDNA-MRD monitoring uncovers occult progression despite radiologic response in locally advanced hypopharyngeal carcinoma: a case report. PubMed 41971451
- World J Otorhinolaryngol Head Neck Surg, 2025 (senior author): Developing a multi-modal MRI radiomics-based model to predict the long-term overall survival of patients with hypopharyngeal cancer receiving definitive radiotherapy. PubMed 40932929
- Front Oncol, 2025 (senior author): Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC. PubMed 40458723
- Oral Oncol, 2025 (senior author): The characterization of tumor immune microenvironment after neoadjuvant immunotherapy in head and neck squamous cell cancer using multiplex immunohistochemistry. PubMed 39746266
- Gland Surg, 2024 (senior author): Comparison of thyroid surgery techniques: a retrospective cohort study and meta-analysis of traditional electric knife vs. straight bipolar electrocoagulation forceps. PubMed 39175701
- Cancer Med, 2024 (senior author): The machine learning-based model for lateral lymph node metastasis of thyroid medullary carcinoma improved the prediction ability of occult metastasis. PubMed 38808852
- BMC Med Imaging, 2024 (senior author): Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer. PubMed 38500053
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion